Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Finasteride appears safe for long-term sperm concentration, but more research is needed for clear conclusions.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Uterine transplants for transgender women are feasible but need more research.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

The effects of estrogen on human hair growth are unclear and need more research.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Hair loss in postmenopausal woman caused by ovarian issue.

Increased PPARGC1α relates to hair thinning in common baldness.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Taking a daily multivitamin may be enough to promote hair growth in people with alopecia.

More research is needed to improve lower body gender affirmation techniques.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.